The cytokines. An overview.

The Cytokine Handbook

Volumn , Issue , 2003, Pages 3-18

  Vilček, Jan ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942890321     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50005-3     Document Type: Chapter

References (113)

1. Aarden L.A., Brunner T.K., Cerottini J.-C., et al. Revised nomenclature for antigen-nonspectific T cell proliferation and helper factors. J. Immunol. 1979, 123:2928-2929.
2. Abreu-Martin M.T., Vidrich A., Lynch D.H., Targan S.R. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen. J. Immunol. 1995, 155:4147-4154.
3. Aggarwal B.B., Eessalu T.E., Hass P.E. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 1985, 318:665-667.
4. Bach E.A., Tanner J.W., Marsters S., et al. Ligandinduced assembly and activation of the gamma interferon receptor in intact cells. Mol. Cell. Biol. 1996, 16:3214-3221.
5. Bazan J.F. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor β-chain. Biochem. Biophys. Res. Comm. 1989, 164:788-795.
6. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA 1990, 87:6934-6938.
7. Bazan J.F. Unraveling the structure of IL-2. Science 1992, 257:410-413.
8. Beresini M.H., Lempert M.J., Epstein L.B. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-α, interferon-γ, interleukin 1α, interleukin 1β, and tumor necrosis factor. J. Immunol. 1988, 140:485-493.
9. Biron C.A., Sen G.C. Interferons and other cytokines. Field's Virology 2001, 321-351. Lippincott Williams & Wilkin, Philadelphia. 4th edn. D.M. Knipe, P.M. Howley (Eds.).
10. Bloom B.R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966, 153:80-82.
11. Bodmer J.L., Schneider P., Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 2002, 27:19-26.
12. Boulay J.L., Paul W.E. The interleukin-4 family of lymphokines. Curr. Opin. Immunol. 1992, 4:294-298.
13. Bradley T.R., Metcalf D. The growth of mouse bone marrow cells in vitro. Aust. J. Exptl. Biol. Med. Sci. 1966, 44:287-299.
14. Callrd R., George A.J., Stark J. Cytokines, chaos, and complexity. Immunity 1999, 11:507-513.
15. Carswell E.A., Old L.J., Kassel R.L., et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl Acad. Sci. USA 1975, 72:3666-3670.
16. Castellino A.M., Chao M.V. Trans-signaling by cytokine and growth factor receptors. Cytokine Growth Factor Rev. 1996, 7:297-302.
17. Cohen S., Bigazzi P.E., Yoshida T. Commentary. Similarities of T cell function in cell-mediated immunity and antibody production. Cell. Immunol. 1974, 12:150-159.
18. Collar M.A., Belin D., Vassalli J.-D., et al. γ-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 1986, 164:2113-2118.
19. Content J., De Wit L., Poupart P., et al. Induction of a 26-kDa protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor. Eur. J. Biochem. 1985, 152:253-257.
20. D'Andrea A.D., Fasman G.D., Lodish H.F. Erythropoietin receptor and interleukin-2 receptor beta chain: a new receptor family. Cell 1989, 58:1023-1024.
21. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
22. David J.R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 1966, 56:72-77.
23. de Larco J.E., Todaro G.J. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl Acad. Sci. USA 1978, 75:4001-4005.
24. De Maeyer E., De Maeyer-Guignard J. Interferons and Other Regulatory Cytokines 1988, John Wiley & Sons, New York.
25. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 1988, 141:2407-2412.
26. Domanski P., Colamonici O.R. The type-I interferon receptor. The long and short of it. Cytokine Growth Factor Rev. 1996, 7:143-151.
27. Dumonde D.C., Wolstencroft R.A., Panayi G.S., et al. 'Lymphokines': non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature 1969, 224:38-42.
28. Feinman R., Henriksen-DeStefano D., Tsujimoto M., Vilcek J. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J. Immunol. 1987, 138:635-640.
29. Fiorentino D.F., Zlotnik A., Vieira P., et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991, 146:3444-3451.
30. Flandes K.C., Roberts A.B. TGF-β. Cytokine Reference 2001, 719-746. Academic Press, San Diego. J.J. Oppenhein, M. Feldmann (Eds.).
31. Flesch I.E.A., Hess J.H., Huang S., et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 1995, 181:1615-1621.
32. Fort M.M., Cheung J., Yen D., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001, 6:985.
33. Fransen L., Van der Heyden J., Ruysschaert R., Fiers W. Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell lines. Eur. J. Cancer Clin. Oncol. 1986, 22:419-426.
34. Fujita T., Reis L.F.L., Watanabe N., et al. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl Acad. Sci. USA 1989, 86:9936-9940.
35. Gearing D.P., King J.A., Gough N.M., Nicola N.A. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J. 1989, 8:3667-3676.
36. Gery I., Gershon R.K., Waksman B.H. Potentiation of cultured mouse thymocyte responses by factors released by peripheral leucocyte. J. Immunol. 1971, 107:1778-1780.
37. Ghayur T., Banerjee S., Hugunin M., et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997, 386:619-623.
38. Greenfeder S.A., Nunes P., Kwee L., et al. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 1995, 270:13757-13765.
39. Grogan J.L., Mohrs M., Harmon B., et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 2001, 14:205-215.
40. Hatakeyama M., Tsudo M., Minamoto S., et al. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNA's. Science 1989, 244:551-556.
41. Hirano T. Interleukin 6 and its receptor: ten years later. Intl. Rev. Immunol. 1998, 16:249-284.
42. Ho A.S.Y., Liu Y., Khan T.A., et al. A receptor for interleukin 10 is related to interferon receptors. Proc. Natl. Acad. Sci. USA 1993, 90:11267-11271.
43. Holtmann H., Wallach D. Down-regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 β-phorbol-12-myristate-13-acetate. J. Immunol. 1987, 139:1161-1167.
44. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev. 2001, 12:313-335.
45. Hotamisligil G.S., Murray D.L., Choy L.N., Spiegelman B.M. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl Acad. Sci. USA 1994, 91:4854-4858.
46. Hsu H., Shu H.-B., Pan M.-G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction path-ways. Cell 1996, 84:299-308.
47. Ihle J.N. Cytokine receptor signalling. Nature 1995, 377:591-594.
48. International Union of Immunological Societies/World Health Organization Subcommittee on Chemokine Nomenclature Chemokine/chemokine receptor nomenclature. J. Leuk. Biol. 2001, 70:465-466.
49. Isaacs A., Lindenmann J. Virus interference. 1. The interferon. Proc. R. Soc. Lond. B 1957, 147:258-267.
50. Kamijo R., Shapiro D., Le J., Huang S., et al. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon γ receptor. Proc. Natl. Acad. Sci. USA 1993, 90:6626-6630.
51. Kamijo R., Harada H., Matsuyama T., et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994, 263:1612-1615.
52. Karp C.L., van Boxel-Dezaire A.H., Byrnes A.A., Nagelkerken L. Interferon-beta in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10?. Curr. Opin. Neurol. 2001, 14:361-368.
53. Kaye J., Gillis S., Mizel S.B., et al. Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J. Immunol. 1984, 133:1339-1345.
54. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell 1994, 76:253-262.
55. Knappe A., Hor S., Wittman S., Fickenscher H. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J. Virol. 2000, 74:3881-3887.
56. Kotenko S. The family of IL-10-related cytokines: related but to what extent?. Cytokine Growth Factor Rev. 2002, 13:223-240.
57. Le J., Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest. 1987, 56:234-248.
58. Lee S.H., Aggarwal B.B., Rinderknech E., et al. The synergistic anti-proliferative effect of gammainterferon and human lymphotoxin. J. Immunol. 1984, 133:1083-1086.
59. Lee T.H., Lee G.W., Ziff E.B., Vilcek J. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol. Cell. Biol. 1990, 10:1982-1988.
60. Levy D.E., Marié I.I., Smith E., Prakash A. Review: Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J. Interferon Cytokine Res. 2002, 22:87-93.
61. Lin J.X., Leonard W.J. Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev. 1997, 8:313-332.
62. Ling P.D., Warren M.K., Vogel S.N. Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J. Immunol. 1985, 135:1857-1863.
63. Lowenthal J.W., Ballard D.W., Bogerd H., et al. Tumor necrosis factor-α activation of the IL-2 receptor-α gene involves the induction of kB-specific DNA binding proteins. J. Immunol. 1989, 142:3121-3128.
64. Lu L., Walker D., Graham C.D., et al. Enhancement of release from MHC class II antigen-positive monocytes of hematopoietic colony stimulating factors CSF-1 and G-CSF by recombinant human tumor necrosis factor-α: synergism with recombinant human interferon-γ. Blood 1988, 72:34-41.
65. Massagué J. How cells read TGF-beta signals. Nat. Rev. Mol. Biol. 2000, 1:169-178.
66. Matsui K., Nakanishi K., Cohen D.I., et al. B cell response pathways regulated by IL-5 and IL-2. Secretory microH chain-mRNA and J chain mRNA expression are separately controlled events. J. Immunol. 1989, 142:2918-2923.
67. Matsushima K., Morishita K., Morishita K., Yoshimura T., et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 1988, 167:1883-1893.
68. Minty A., Chalon P., Derocq J.-M., et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362:248-250.
69. Morgan D.A., Ruscetti F.W., Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 1976, 193:1007-1008.
70. Murphy P.M. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 1996, 7:47-64.
71. Nagata S. Fas ligand-induced apoptosis. Ann. Rev. Genet. 1999, 33:29-55.
72. Neta R., Sayers T.J., Oppenheim J.J. Relationship of TNF to interleukins. Tumor Necrosis Factors: Structure, Function, and Mechanism of Action 1992, 499-566. Marcel Dekker, New York. B.B. Aggarwal, J. Vilcek (Eds.).
73. Noma T., Mizuta T., Rosen A., et al. Enhancement of the interleukin 2 receptor expression on T cells by multiple B-lymphotropic lymphokines. Immunol. Lett. 1987, 15:249-253.
74. O'Garra A., Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 2000, 10:542-550.
75. O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2000, 44. http://www.stke.org/cgi/content/full/OC_sigtrans;2000/44/rel.
76. O'Neill L.A., Dower S.K. IL-1 receptor family. Cytokine Reference 2001, 1565-1586. Academic Press, San Diego. J.J. Oppenheim, M. Feldmann (Eds.).
77. Oppenheim J.J., Mizel S.B., Meltzer M.S. Biological effects of lymphocyte and macrophage-derived mitogenic 'amplification' factors. Biology of the Lymphokines 1979, 291-323. Academic Press, New York. S. Cohen, E. Pick, J.J. Oppenheim (Eds.).
78. Pellegrini S., Schindler C. Early events in signalling by interferons. Trends Biochem. Sci. 1993, 18:338-342.
79. Pestka S., Kotenko S.V., Muthukumaran G., et al. The interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev. 1997, 8:189-206.
80. Pine R. Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element. Nucleic Acids Res. 1997, 25:4346-4354.
81. Raitano A.B., Korc M. Tumor necrosis factor upregulates γ-interferon binding in a human carcinoma cell line. J. Biol. Chem. 1990, 265:10466-10472.
82. Reddi A.H. BMP receptor. Cytokine Reference 2001, 1885-1888. Academic Press, San Diego. J.J. Oppenheim, M. Feldmann (Eds.).
83. Rengarajan J., Szabo S.J., Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol. Today 2000, 21:479-483.
84. Roberts A.B., Sporn M.B. The transforming growth factor-βs. Peptide Growth Factors and Their Receptors I 1990, 419-472. Springer-Verlag, Berlin. M.B. Sporn, A.B. Roberts (Eds.).
85. Roberts W.M., Look A.T., Roussel M.F., Sherr C.J. Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes. Cell 1988, 55:655-661.
86. Ruddle N.H., Waksman B.H. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism. J. Exp. Med. 1968, 128:1267-1279.
87. Sachs L. The molecular control of blood cell development. Science 1987, 238:1374-1379.
88. Sato M., Taniguchi T., Tanaka N. The interferon system and interferon regulatory factor transcription factors-studies from gene knockout mice. Cytokine Growth Factor Rev. 2001, 12:133-142.
89. Siegal F.P., Kadowaki N., Shodell M., et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
90. Sims J.E., Gayle M.A., Slack J.L., et al. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 1993, 90:6155-6159.
91. Sims J.E., Nicklin M.J.H., Bazan F., et al. A new nomenclature for IL-1 family genes. Trends Immunol. 2001, 22:536-537.
92. Smith K.A. Interleukin-2: inception, impact, and implications. Science 1988, 240:1169-1176.
93. Smith K.A., Lachman L.B., Oppenheim J.J., Favata M.F. The functional relationship of the interleukins. J. Exp. Med. 1980, 151:1551-1556.
94. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994, 76:959-962.
95. Snapper C.M., Finkelman F.D., Paul W.E. Regulation of IgG1 and IgE production by interleukin 4. Immunol. Rev. 1988, 102:51-75.
96. Sporn M.B., Roberts A.B. Peptide growth factors are multifunctional. Nature 1988, 332:217-219.
97. Stark G.R., Kerr I.M., Williams B.R., et al. How cells respond to interferons. Ann. Rev. Biochem. 1998, 67:227-264.
98. Svedersky L.P., Nedwin G.E., Goeddel D.V., Palladino M.A. Interferon-γ enhances induction of lymphotoxin in recombinant interleukin 2-stimulated peripheral blood mononuclear cells. J. Immunol. 1985, 134:1604-1608.
99. Taga T., Kishimoto T. Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr. Opin. Immunol. 1995, 7:17-23.
100. Taniguchi T., Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 2002, 14:111-116.
101. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 2001, 19:623-655.
102. Torres B.A., Farrar W.L., Johnson H.M. Interleukin 2 regulates immune interferon (IFN γ) production by normal and suppressor cell cultures. J. Immunol. 1982, 128:2217-2219.
103. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995, 13:251-276.
104. Trinchieri G., Kobayashi M., Rosen M., et al. Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J. Exp. Med. 1986, 164:1206-1225.
105. Vilcek J., Sen G.C. Interferons and other cytokines. Field's Virology 1996, 375-399. Lippincott-Raven, Philadelphia. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
106. Wallach D., Varfolomeev E.E., Malinin N.L., et al. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 1999, 17:331-367.
107. Wheelock E.F. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 1965, 149:310-311.
108. Williams T.W., Granger G.A. Lymphocyte in vitro cytotoxicity: lymphotoxins of several mammalian species. Nature 1968, 219:1076-1077.
109. Wong G.H.W., Goeddel D.V. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 1986, 323:819-822.
110. Wrana J.L., Attisano L. The Smad pathway. Cytokine Growth Factor Rev. 2000, 11:513.
111. Wu D., LaRosa G.J., Simon M.I. G protein-coupled signal transduction pathways for interleukin-8. Science 1993, 261:101-103.
112. Zhang Y., Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol. 1999, 9:4-9.
113. Zucali J.R., Dinarello C.A., Oblon D.J., et al. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J. Clin. Invest. 1986, 77:1857-1863.